ArcticZymes Technologies ASA (OSL:AZT) LT-Debt-to-Total-Asset : 0.02 (As of Mar. 2024)

View and export this data going back to 2005. Start your Free Trial

What is ArcticZymes Technologies ASA LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. ArcticZymes Technologies ASA's long-term debt to total assests ratio for the quarter that ended in Mar. 2024 was 0.02.

ArcticZymes Technologies ASA's long-term debt to total assets ratio declined from Mar. 2023 (0.03) to Mar. 2024 (0.02). It may suggest that ArcticZymes Technologies ASA is progressively becoming less dependent on debt to grow their business.

ArcticZymes Technologies ASA LT-Debt-to-Total-Asset Historical Data

The historical data trend for ArcticZymes Technologies ASA's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ArcticZymes Technologies ASA LT-Debt-to-Total-Asset Chart

ArcticZymes Technologies ASA Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

0.16

0.04

0.05

0.03

ArcticZymes Technologies ASA Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial															0.03	0.03	0.03	0.03	0.02

ArcticZymes Technologies ASA LT-Debt-to-Total-Asset Calculation

ArcticZymes Technologies ASA's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

LT Debt to Total Assets (A: Dec. 2023 )	=	Long-Term Debt & Capital Lease Obligation (A: Dec. 2023 )	/	Total Assets (A: Dec. 2023 )
	=	8.414	/	339.323
	=	0.02

ArcticZymes Technologies ASA's Long-Term Debt to Total Asset Ratio for the quarter that ended in Mar. 2024 is calculated as

LT Debt to Total Assets (Q: Mar. 2024 )	=	Long-Term Debt & Capital Lease Obligation (Q: Mar. 2024 )	/	Total Assets (Q: Mar. 2024 )
	=	6.905	/	342.778
	=	0.02

ArcticZymes Technologies ASA (OSL:AZT) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

ArcticZymes Technologies ASA LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of ArcticZymes Technologies ASA's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

ArcticZymes Technologies ASA (OSL:AZT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ArcticZymes Technologies ASA (OSL:AZT) » Definitions » LT-Debt-to-Total-Asset

Comparable Companies

Traded in Other Exchanges

B4V:Germany

Address

Sykehusveien 23, Tromso, NOR, N-9294

Website

https://www.arcticzymes.com

ArcticZymes Technologies ASA is a biotechnology company. The company is engaged in developing, producing, and marketing immune-modulating beta-glucans and novel recombinant enzymes. The company's products include Woulgan wound gel, Feed Ingredient (M-Glucan), Nutraceuticals (M-Gard), Recombinant enzymes, and others. The company reports in two operating segments that are Enzymes and Corporate. Geographically, it derives a majority of revenue from the USA.

ArcticZymes Technologies ASA (OSL:AZT) Headlines

No Headlines